Search research articles
Contact Us
Filters
Showing results (111-120 of 150) with videos related to
Page
of 15
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 19, 2019
Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple Myeloma
Ang Li, Qian Wu, Suhong Luo, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 31, 2022
Standardization of risk prediction model reporting in cancer-associated thrombosis: Communication from the ISTH SSC subcommittee on hemostasis and malignancy
Kristen M Sanfilippo, Tzu-Fei Wang, Marc Carrier, et al.
Pharmacoepidemiology and Drug Safety
|
February 9, 2010
Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population
Peter M Wahl, Keith Rodgers, Sebastian Schneeweiss, et al.
Cardiology Research and Practice
|
October 24, 2022
Predicting Postoperative Troponin in Patients Undergoing Elective Hip or Knee Arthroplasty: A Comparison of Five Cardiac Risk Prediction Tools
Merih T Tesfazghi, Anne R Bass, Noor Al-Hammadi, et al.
Circulation
|
March 27, 2012
Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis
Brian R Lindman, Alan Zajarias, José A Madrazo, et al.
JACC. Heart Failure
|
February 10, 2015
Clinical outcomes with use of erythropoiesis stimulating agents in patients with the HeartMate II left ventricular assist device
Michael E Nassif, Jayendrakumar S Patel, Jerrica E Shuster, et al.
The New England Journal of Medicine
|
June 3, 2005
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
Mark J Rieder, Alexander P Reiner, Brian F Gage, et al.
The Annals of Pharmacotherapy
|
October 4, 2007
Optimal initial dose adjustment of warfarin in orthopedic patients
Petra A Lenzini, Gloria R Grice, Paul E Milligan, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
January 24, 2007
Improving adherence to coronary heart disease secondary prevention medication guidelines at a community hospital
Thomas C Bailey, Laura A Noirot, Brian F Gage, et al.
Thrombosis and Haemostasis
|
April 21, 2005
Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype
Deepak Voora, Charles Eby, Mark W Linder, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 150) with videos related to
Sort By:
Page
of 15
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 19, 2019
Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple Myeloma
Ang Li, Qian Wu, Suhong Luo, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 31, 2022
Standardization of risk prediction model reporting in cancer-associated thrombosis: Communication from the ISTH SSC subcommittee on hemostasis and malignancy
Kristen M Sanfilippo, Tzu-Fei Wang, Marc Carrier, et al.
Pharmacoepidemiology and Drug Safety
|
February 9, 2010
Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population
Peter M Wahl, Keith Rodgers, Sebastian Schneeweiss, et al.
Cardiology Research and Practice
|
October 24, 2022
Predicting Postoperative Troponin in Patients Undergoing Elective Hip or Knee Arthroplasty: A Comparison of Five Cardiac Risk Prediction Tools
Merih T Tesfazghi, Anne R Bass, Noor Al-Hammadi, et al.
Circulation
|
March 27, 2012
Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis
Brian R Lindman, Alan Zajarias, José A Madrazo, et al.
JACC. Heart Failure
|
February 10, 2015
Clinical outcomes with use of erythropoiesis stimulating agents in patients with the HeartMate II left ventricular assist device
Michael E Nassif, Jayendrakumar S Patel, Jerrica E Shuster, et al.
The New England Journal of Medicine
|
June 3, 2005
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
Mark J Rieder, Alexander P Reiner, Brian F Gage, et al.
The Annals of Pharmacotherapy
|
October 4, 2007
Optimal initial dose adjustment of warfarin in orthopedic patients
Petra A Lenzini, Gloria R Grice, Paul E Milligan, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium
|
January 24, 2007
Improving adherence to coronary heart disease secondary prevention medication guidelines at a community hospital
Thomas C Bailey, Laura A Noirot, Brian F Gage, et al.
Thrombosis and Haemostasis
|
April 21, 2005
Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype
Deepak Voora, Charles Eby, Mark W Linder, et al.
Page
of 15